News/ News/ R&D GSK ends 2020 with multi-million dollar deal frenzy to boost R&D Richard Staines Adestia Therapeutics, GlaxoSmithKline, Ligand Therapeutics, R&D, Sosei Heptares, Surface Oncology 0 Comment GlaxoSmithKline has closed the year with a flurry of deals, leaving its development pipeline bulging like Santa’s sack Share X GSK ends 2020 with multi-million dollar deal frenzy to boost R&D https://pharmaphorum.com/news/gsk-closes-2020-with-four-deals/